Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Labcorp Holdings ( (LH) ) just unveiled an update.
On January 15, 2026, Labcorp Holdings announced plans to release its financial results for the fourth quarter of 2025 before the market opens on Tuesday, February 17, 2026, followed by a 9 a.m. ET conference call and webcast for investors and analysts. The earnings release, detailed financial information, and a replay of the webcast—available for nearly a year, until February 4, 2027—will be accessible via the company’s investor relations website, signaling Labcorp’s continued emphasis on transparency and engagement with the financial community as it reports on its recent operating performance.
The most recent analyst rating on (LH) stock is a Hold with a $273.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
The score is driven primarily by solid financial performance (notably strong cash flow) and a positive earnings outlook with raised free-cash-flow guidance. These strengths are tempered by softer technical momentum (negative MACD and trading below key moving averages) and a valuation that is reasonable but not notably cheap.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. (NYSE: LH) is a global leader in innovative and comprehensive laboratory services, providing diagnostics and drug development capabilities that help doctors, hospitals, pharmaceutical companies, researchers and patients make informed decisions. With nearly 70,000 employees serving clients in about 100 countries, the company performs more than 700 million tests annually and supported over 75% of new drugs and therapeutic products approved by the U.S. FDA in 2024, underscoring its central role in global healthcare and biopharmaceutical development.
Average Trading Volume: 840,647
Technical Sentiment Signal: Buy
Current Market Cap: $21.72B
See more data about LH stock on TipRanks’ Stock Analysis page.